This is a biased opinion as I truly believe the Psychedelic stock market will be expanding more and more in the years to come.
Hence my long term bullish approach.
Mindmed has been in a downtrend since Q3 21.
Early February, price was rejected at yearly open. I do not think this reflects the company value but rather a market sentiment.
Earnings early march might give some volume.
Investment thesis is as follow:
I want to support companies that are working towards a better understanding of mental health issues, but I want my support to be as efficient as possible considering the economic uncertainties that surrounds the global market.
Price target for 2023: 5-8$
What do you think ?
Hence my long term bullish approach.
Mindmed has been in a downtrend since Q3 21.
Early February, price was rejected at yearly open. I do not think this reflects the company value but rather a market sentiment.
Earnings early march might give some volume.
Investment thesis is as follow:
I want to support companies that are working towards a better understanding of mental health issues, but I want my support to be as efficient as possible considering the economic uncertainties that surrounds the global market.
- Either price reclaim yearly open if
XBI
and
IWM
rally/bounce
- Downfall across the market continues--> buying between 55-80cent/share for best r:r
Price target for 2023: 5-8$
What do you think ?